AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32005604 — intervention group
Group type: COMPARATOR
Intervention: Control group received a typical hospital cotton blanket.
Number of subjects: 54
Study 32564571 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg bid
Number of subjects: 61
Study 32564571 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 45 mg bid
Number of subjects: 61
Study 32564571 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg qd
Number of subjects: 61
Study 32665433 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg
Number of subjects: 149
Study 32665433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 32665433 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab (after crossover from placebo)
Number of subjects: 149
Study 32665433 — intervention group
Group type: EXPERIMENTAL
Intervention: Guselkumab
Number of subjects: 149
Study 35700523 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin analogue lash lengtheners (PGALLs) containing isopropyl cloprostenate
Number of subjects: 15
Study 35700523 — intervention group
Group type: COMPARATOR
Intervention: Non-prostaglandin analogue lash lengtheners (NPGALLs)
Number of subjects: 15
Study 35700523 — intervention group
Group type: COMPARATOR
Intervention: False eyelashes (FLs)
Number of subjects: 15
Study 33150481 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-367 treatment in erythrocyte lysate-treated microglia
Number of subjects: 0
Study 33150481 — intervention group
Group type: EXPERIMENTAL
Intervention: miR-367 mimic in the presence of CEBPA
Number of subjects: 0
Study 33150481 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 36402857 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined laser iridoplasty followed by surgical iridectomy (LI-SI)
Number of subjects: 67
Study 36402857 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 67
Study 32152145 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciliary neurotrophic factor (CNTF) treatment
Number of subjects: 51
Study 32152145 — intervention group
Group type: COMPARATOR
Intervention: Control (sham eyes)
Number of subjects: 51
Study 33006400 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate colposcopy (IC)
Number of subjects: 2661
Study 33006400 — intervention group
Group type: EXPERIMENTAL
Intervention: hrHPV testing (HPV)
Number of subjects: 2661
Study 33006400 — intervention group
Group type: COMPARATOR
Intervention: Conventional cytology at 6 and 12 months (RC)
Number of subjects: 2661
Study 34799125 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (100 mg)
Number of subjects: 46
Study 34799125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 33678496 — intervention group
Group type: EXPERIMENTAL
Intervention: Animation (n = 212)
Number of subjects: 606
Study 33678496 — intervention group
Group type: COMPARATOR
Intervention: Leaflet with images (n = 197)
Number of subjects: 606
Study 33678496 — intervention group
Group type: COMPARATOR
Intervention: Leaflet with text only (n = 197)
Number of subjects: 606
Study 32083646 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐carotene + fermented milk
Number of subjects: 16
Study 32083646 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrot + fermented milk
Number of subjects: 16
Study 32083646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato + fermented milk
Number of subjects: 16
Study 32083646 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinach + fermented milk
Number of subjects: 16
Study 32083646 — intervention group
Group type: COMPARATOR
Intervention: β‐carotene only
Number of subjects: 16
Study 32083646 — intervention group
Group type: COMPARATOR
Intervention: Carrot drink alone
Number of subjects: 16
Study 32083646 — intervention group
Group type: COMPARATOR
Intervention: Tomato drink alone
Number of subjects: 16
Study 32083646 — intervention group
Group type: COMPARATOR
Intervention: Spinach drink alone
Number of subjects: 16
Study 33100326 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL increase (1 SD = 12.26 mg/dL)
Number of subjects: 69374
Study 33100326 — intervention group
Group type: EXPERIMENTAL
Intervention: TG increase (1 SD = 112.33 mg/dL)
Number of subjects: 69374
Study 32171780 — intervention group
Group type: EXPERIMENTAL
Intervention: Think/No‐Think task with food specific cues
Number of subjects: 61
Study 32171780 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher emotional eating
Number of subjects: 61
Study 33875433 — intervention group
Group type: EXPERIMENTAL
Intervention: NTM-1632 (0.033 mg/kg)
Number of subjects: 24
Study 33875433 — intervention group
Group type: EXPERIMENTAL
Intervention: NTM-1632 (0.165 mg/kg)
Number of subjects: 24
Study 33875433 — intervention group
Group type: EXPERIMENTAL
Intervention: NTM-1632 (0.330 mg/kg)
Number of subjects: 24
Study 33875433 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study 33568226 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated iodine complex of 200 mg (arm A)
Number of subjects: 200
Study 33568226 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine complex syrup form 40 ml (arm B)
Number of subjects: 200
Study 33568226 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine complex throat spray of 2 puffs (arm C)
Number of subjects: 200
Study 33568226 — intervention group
Group type: COMPARATOR
Intervention: Empty capsule (arm D) as placebo
Number of subjects: 200
Study 33568226 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms (A, B, C, D)
Number of subjects: 200
Study 33044292 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled colonic J-pouch
Number of subjects: 379
Study 33044292 — intervention group
Group type: COMPARATOR
Intervention: Straight colorectal anastomosis
Number of subjects: 379
Study 33044292 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 379
Study 35445723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixantrone 180 mg/m2 every 3 weeks (group A)
Number of subjects: 45
Study 35445723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixantrone 85 mg/m2 on days 1, 8, and 15 of a 28-day cycle (group B)
Number of subjects: 45
Study 34499820 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol nebulized with 3% hypertonic saline (HSS)
Number of subjects: 50
Study 34499820 — intervention group
Group type: COMPARATOR
Intervention: Albuterol nebulized with normal saline solution (NSS)
Number of subjects: 50
Study 32169140 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended Learning (BL)
Number of subjects: 0
Study 32169140 — intervention group
Group type: COMPARATOR
Intervention: Traditional Lecturing (TL)
Number of subjects: 0
Study 35239778 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction therapy
Number of subjects: 96
Study 35239778 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 96
Study 33070249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rh‐endostatin plus paclitaxel/nedaplatin
Number of subjects: 53
Study 33550546 — intervention group
Group type: EXPERIMENTAL
Intervention: Capno + group (nurses managed patients with access to the capnometer and PETCO2 measurements)
Number of subjects: 48
Study 33550546 — intervention group
Group type: COMPARATOR
Intervention: Capno - group (nurses monitored patients without seeing PETCO2 measurements)
Number of subjects: 48
Study 34540780 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga program for T2DM prevention (YOGA-DP)
Number of subjects: 14
Study 36104128 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral intake of LC-Plasma-containing capsule, 200 mg/day, for 14 days
Number of subjects: 100
Study 36104128 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule, for 14 days
Number of subjects: 100
Study 34441810 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing intervention (yoga-based breathing intervention)
Number of subjects: 46
Study 34441810 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 33163715 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified low-phosphorus diet
Number of subjects: 74
Study 33163715 — intervention group
Group type: COMPARATOR
Intervention: Standard low-phosphorus diet
Number of subjects: 74
Study 33163715 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 74
Study 35216868 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulation of Craving Training (ROC-T)
Number of subjects: 93
Study 35216868 — intervention group
Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 93
Study 34229051 — intervention group
Group type: EXPERIMENTAL
Intervention: NIMO‐CCRT (CCRT with 200 mg of nimotuzumab administered weekly by intravenous infusion)
Number of subjects: 122
Study 34229051 — intervention group
Group type: COMPARATOR
Intervention: CCRT (65 Gy thoracic radiation over 5 weeks concurrent with docetaxel and cisplatin)
Number of subjects: 122
Study 34229051 — intervention group
Group type: EXPERIMENTAL
Intervention: NIMO‐CCRT
Number of subjects: 122
Study 34229051 — intervention group
Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 122
Study 33638104 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted cholecystectomy (RAC)
Number of subjects: 40
Study 33638104 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 40
Study 33253664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injection 2 mg every 4 weeks (2q4)
Number of subjects: 113
Study 33253664 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept injection 2 mg every 8 weeks (2q8)
Number of subjects: 113
Study 34013755 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 70
Study 34013755 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning (SAT)
Number of subjects: 70
Study 34013755 — intervention group
Group type: EXPERIMENTAL
Intervention: AET
Number of subjects: 70
Study 34013755 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 35945514 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative anal dilatation using a 33 mm anal dilator for 20 min
Number of subjects: 40
Study 35945514 — intervention group
Group type: COMPARATOR
Intervention: No preoperative anal dilatation
Number of subjects: 40
Study 35945514 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative anal dilatation
Number of subjects: 40
Study 33759389 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotype-guided treatment with antiobesity medications (phentermine, phentermine/topiramate, bupropion/naltrexone, lorcaserin, liraglutide)
Number of subjects: 450
Study 33759389 — intervention group
Group type: COMPARATOR
Intervention: Non-phenotype-guided treatment with antiobesity medications
Number of subjects: 450
Study 35978437 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-based digital healthcare system
Number of subjects: 115
Study 35978437 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 115
Study 33691612 — intervention group
Group type: EXPERIMENTAL
Intervention: RicePro (2×20g of protein)
Number of subjects: 70
Study 33691612 — intervention group
Group type: EXPERIMENTAL
Intervention: WheyPro (2×20g of protein)
Number of subjects: 70
Study 33691612 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 70
Study 32031726 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional injection of MMR vaccine
Number of subjects: 48
Study 32031726 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 48
Study 33550239 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation with 3D printed patient-specific jig
Number of subjects: 36
Study 33550239 — intervention group
Group type: COMPARATOR
Intervention: Operation without jig
Number of subjects: 36
Study 32664987 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby-Friendly Community Initiative (BFCI) intervention with 12 personalized home-based counselling sessions
Number of subjects: 901
Study 32664987 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby-Friendly Community Initiative (BFCI) intervention
Number of subjects: 901
Study 36308244 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene block
Number of subjects: 40
Study 36308244 — intervention group
Group type: EXPERIMENTAL
Intervention: Infraclavicular block
Number of subjects: 40
Study 36308244 — intervention group
Group type: COMPARATOR
Intervention: Control (non-blocked arm)
Number of subjects: 40
Study 34379090 — intervention group
Group type: EXPERIMENTAL
Intervention: Omnigenic Mendelian randomization (OMR) method using all genome-wide SNPs for causal inference
Number of subjects: 0
Study 34260542 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred Stenting (DS)
Number of subjects: 114
Study 34260542 — intervention group
Group type: COMPARATOR
Intervention: Immediate Stenting (IS)
Number of subjects: 114
Study 32332810 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training for 25 minutes prior to 65 minutes of Structured Progressive Circuit Class Therapy (SPCCT)
Number of subjects: 40
Study 32332810 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE) for 25 minutes prior to 65 minutes of Structured Progressive Circuit Class Therapy (SPCCT)
Number of subjects: 40
Study 32332810 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI) training
Number of subjects: 40
Study 32332810 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 40
Study 35184629 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based Dyadic Life Review Program
Number of subjects: 47
Study 34000607 — intervention group
Group type: EXPERIMENTAL
Intervention: Drive and Retrieve System (DRS) with an additional neurointerventionist allocated for DRS
Number of subjects: 0
Study 34000607 — intervention group
Group type: COMPARATOR
Intervention: Current scenario (control) where patients received endovascular thrombectomy in facilities where specialists normally work
Number of subjects: 0
Study 32191328 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery prize amount won (ranging from $0 to $1.6 million)
Number of subjects: 4820
Study 36041708 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 1 mg on days 1-7, 0.5 mg on days 8-14
Number of subjects: 39
Study 36041708 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg per day for 14 days
Number of subjects: 39
Study 36041708 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 2 mg on day 1, 1 mg on days 2-7, 0.5 mg on days 8-14
Number of subjects: 39
Study 36041708 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 3 mg on day 1, 1 mg on days 2-7, 0.5 mg on days 8-14
Number of subjects: 39
Study 33704936 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step screening (75-g glucose load, fasting state)
Number of subjects: 23792
Study 33704936 — intervention group
Group type: COMPARATOR
Intervention: Two-step screening (50-g glucose load, nonfasting state followed by 100-g glucose load, fasting state)
Number of subjects: 23792
Study 33704936 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step screening
Number of subjects: 23792
Study 33704936 — intervention group
Group type: COMPARATOR
Intervention: Two-step screening
Number of subjects: 23792
Study 32856709 — intervention group
Group type: EXPERIMENTAL
Intervention: Low salt diet (1,500 mg/d)
Number of subjects: 157
Study 32856709 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium salt diet (2,400 mg/d)
Number of subjects: 157
Study 32856709 — intervention group
Group type: EXPERIMENTAL
Intervention: High salt diet (3,300 mg/d)
Number of subjects: 157
Study 32856709 — intervention group
Group type: EXPERIMENTAL
Intervention: Uromodulin levels
Number of subjects: 157
Study 35378544 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive mirror therapy (5 times/week for 6 weeks)
Number of subjects: 40
Study 35378544 — intervention group
Group type: COMPARATOR
Intervention: Spaced mirror therapy (3 times/week for 10 weeks)
Number of subjects: 40
Study 33128635 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for vitamin D deficiency based on clinical characteristics
Number of subjects: 4073
Study 33128635 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-European ethnicity
Number of subjects: 4073
Study 33128635 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis using deseasonalised serum 25OHD (DS‐25OHD) as the dependent variable
Number of subjects: 4073
Study 33128635 — intervention group
Group type: EXPERIMENTAL
Intervention: DS‐25OHD < 40 nmol/L
Number of subjects: 4073
Study 35050697 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish support intervention
Number of subjects: 56
Study 35050697 — intervention group
Group type: COMPARATOR
Intervention: Spanish support control
Number of subjects: 56
Study 35230249 — intervention group
Group type: EXPERIMENTAL
Intervention: Community volunteers (CVs) tracking children's vaccination status and demographic movements, organizing monthly catch-up immunization sessions via WhatsApp.
Number of subjects: 1260
Study 33394039 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound surveillance
Number of subjects: 95
Study 33632035 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear of COVID-19
Number of subjects: 215
Study 33632035 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety of COVID-19
Number of subjects: 215
Study 33632035 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived Stress
Number of subjects: 215
Study 33632035 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Care
Number of subjects: 215
Study 34881436 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person family contact
Number of subjects: 155
Study 34881436 — intervention group
Group type: EXPERIMENTAL
Intervention: Text/email/letter with friends
Number of subjects: 155
Study 33355947 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral ACP (Group 1)
Number of subjects: 42
Study 33355947 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ACP (Group 2)
Number of subjects: 42
Study 33355947 — intervention group
Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 42
Study 33086145 — intervention group
Group type: EXPERIMENTAL
Intervention: Real hf-tRNS (100–650 Hz)
Number of subjects: 40
Study 33086145 — intervention group
Group type: COMPARATOR
Intervention: Sham hf-tRNS
Number of subjects: 40
Study 35509819 — intervention group
Group type: EXPERIMENTAL
Intervention: Red ginseng formulation
Number of subjects: 20
Study 35509819 — intervention group
Group type: EXPERIMENTAL
Intervention: Red ginseng formulation with 1,2‐hexanediol
Number of subjects: 20
Study 35509819 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel application
Number of subjects: 20
Study 35509819 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel formulation
Number of subjects: 20
Study 35509819 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall microbial species
Number of subjects: 20
Study 32890813 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine + Sorafenib (GemSorafenib)
Number of subjects: 122
Study 32890813 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine + Placebo (GemP)
Number of subjects: 122
Study 32890813 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy (more than six cycles)
Number of subjects: 122
Study 34695622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical method (balloon catheter)
Number of subjects: 74
Study 34695622 — intervention group
Group type: COMPARATOR
Intervention: Pharmaceutical method (prostaglandins)
Number of subjects: 74
Study 33734765 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength at Home (SAH) intervention
Number of subjects: 23
Study 33367539 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic space closure treatment (TG)
Number of subjects: 44
Study 33367539 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 44
Study 32074652 — intervention group
Group type: EXPERIMENTAL
Intervention: TKA with a tourniquet
Number of subjects: 65
Study 32074652 — intervention group
Group type: COMPARATOR
Intervention: TKA without a tourniquet
Number of subjects: 65
Study 32613752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab (BIIB054) 250 mg every 4 weeks
Number of subjects: 0
Study 32613752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab (BIIB054) 1,250 mg every 4 weeks
Number of subjects: 0
Study 32613752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab (BIIB054) 3,500 mg every 4 weeks
Number of subjects: 0
Study 32613752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab (BIIB054) up to 90 mg/kg
Number of subjects: 0
Study 35007684 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustukhuddus Alavi
Number of subjects: 86
Study 35007684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 34334739 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year TST follow-up
Number of subjects: 1770
Study 34334739 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-year TST follow-up
Number of subjects: 1770
Study 32619413 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ileocaecal resection
Number of subjects: 134
Study 32619413 — intervention group
Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 134
Study 32619413 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 134
Study 32619413 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulator therapy (in addition to allocated treatment)
Number of subjects: 134
Study 35902900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic treatment 1
Number of subjects: 0
Study 35902900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic treatment 2
Number of subjects: 0
Study 35902900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic treatment 3
Number of subjects: 0
Study 35902900 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic treatment 1, 2, and 3
Number of subjects: 0
Study 33097554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of local anaesthetic
Number of subjects: 11
Study 33097554 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia with or without sedation
Number of subjects: 11
Study 35210352 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime antihypertensive administration
Number of subjects: 3227